New Human Medicines: RSS Feed from EMA
- Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion under re-examination
- Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion
- Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Status: Opinion
- Human medicines European public assessment report (EPAR): Denosumab BBL, denosumab, Status: Opinion
- Human medicines European public assessment report (EPAR): Enwylma, denosumab, Status: Opinion
- Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion
- Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Status: Opinion
- Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Status: Opinion
- Human medicines European public assessment report (EPAR): Sephience, sepiapterin, Status: Opinion
- Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Status: Opinion
MedWatch Safety Alert RSS Feed
- FDA and CDC Recommend Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports are Investigated: FDA Safety Communication
- FDA Advises Consumers, Tattoo Artists, and Retailers to Avoid Using or Selling Certain Sacred Tattoo Ink Products Contaminated with Microorganisms
- EnShiShiXiangNiShangMaoYouXianGongSi Issues Voluntary Nationwide Recall of ENDURANCE BOOST WITH HORNY GOAT WEED Capsules Due To Presence of Undeclared Propoxyphenylsildenafil and Sildenafil
- Heart Pump Accessory Removal: Abbott Removes HeartMate Mobile Power Unit due to Instances of Sudden Power Loss
- Risk of False Positive Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication
- Early Alert: Intravascular PICC Catheter Issue from BD
- Early Alert: Diagnostic Intravascular Catheter Issue from Conavi
- Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter
- FDA Classifies Q’Apel Medical Inc.’s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
- Max Mobility / Permobil Expands Nationwide Recall of SmartDrive Speed Control Dial Due to the Motor Being Unresponsive to the User